Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance.
- NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_assertion description "[Recently, several new and specific thymidylate synthase inhibitors that occupy the folate binding site, including Tomudex(R), BW1843U89, and Thymitaq, have demonstrated therapeutic activity in patients with advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance.
- NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_assertion evidence source_evidence_literature NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance.
- NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_assertion SIO_000772 9565579 NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance.
- NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_assertion wasDerivedFrom befree-2016 NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance.
- NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_assertion wasGeneratedBy ECO_0000203 NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance.
- befree-2016 importedOn "2016-02-19" NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance.